{"transactions":[{"id":4536139,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":180680,"kind":"person","name":"TIERNEY THOMAS T","position":1,"cik":"0001571328","reported_name":"TIERNEY THOMAS T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-12-02T21:39:13.000Z","date":"2016-11-30","kind":"grant","acquired":true,"shares":32000,"price":6.25,"value":200000.0,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Purchased in a private placement of securities by the issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are held in the name of the Thomas T. and Elizabeth C. Tierney Family Trust of which Mr. Tierney is a trustee."}],"balance_after":216345,"source":{"system":"sec-edgar","filing":"0001615774-16-008689","document":"s104848_tierney.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577416008689/s104848_tierney.xml","form_type":"4"}},{"id":4570143,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":180680,"kind":"person","name":"TIERNEY THOMAS T","position":1,"cik":"0001571328","reported_name":"TIERNEY THOMAS T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-03T01:11:15.000Z","date":"2016-11-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The award was approved by the board of directors of MYnd Analytics, Inc. (the \"Registrant\") on September 29, 2016, subject to stockholder approval of the Amended and Restated 2012 Omnibus Incentive Compensation Plan (the \"Plan\") under which the award was granted. The Registrant's stockholders approved the Plan on November 1, 2016."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001615774-16-007983","document":"s104520_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577416007983/s104520_form4.xml","form_type":"4"}},{"id":4596766,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":180680,"kind":"person","name":"TIERNEY THOMAS T","position":1,"cik":"0001571328","reported_name":"TIERNEY THOMAS T","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock Warrant","published_at":"2016-09-24T00:27:26.000Z","date":"2016-09-21","kind":"disposition_to_issuer","acquired":false,"reported_value":640000,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"All information provided herein has been adjusted where necessary to give effect to the 1-for-200 reverse stock split effected on September 21, 2016."},{"field":"kind","element":"transactionCoding","label":"F5","text":"The Amendment provided that upon the conversion of the notes issued pursuant to the Note and Warrant Purchase Agreement, which was caused by the Issuer on September 21, 2016, all warrants issued pursuant to the Note and Warrant Purchase Agreement would be cancelled."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Amendment provided that upon the conversion of the notes issued pursuant to the Note and Warrant Purchase Agreement, which was caused by the Issuer on September 21, 2016, all warrants issued pursuant to the Note and Warrant Purchase Agreement would be cancelled."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Common Stock Warrants were exercisable as of their respective dates of issuance."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are held in the name of the Thomas T. and Elizabeth C. Tierney Family Trust of which Mr. Tierney is a trustee."}],"balance_after":0,"derivative":{"exercise_price":10,"expiration_date":"2020-12-31","underlying":"Common Stock","underlying_shares":64000},"source":{"system":"sec-edgar","filing":"0001615774-16-007365","document":"s104200_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577416007365/s104200_form4.xml","form_type":"4"}},{"id":4596765,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":180680,"kind":"person","name":"TIERNEY THOMAS T","position":1,"cik":"0001571328","reported_name":"TIERNEY THOMAS T","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"5% Secured Convertible Note due December 2017","published_at":"2016-09-24T00:27:26.000Z","date":"2016-09-21","kind":"exercise","acquired":false,"reported_value":640000,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"All information provided herein has been adjusted where necessary to give effect to the 1-for-200 reverse stock split effected on September 21, 2016."},{"field":"reported_value","element":"transactionTotalValue","label":"F3","text":"Six notes in the aggregate principal amount of $640,000 were purchased by the Reporting Person between September 22, 2014 and August 3, 2016 pursuant to a Note and Warrant Purchase Agreement, dated as of September 22, 2014, as amended (the \"Note and Warrant Purchase Agreement\"), between the Issuer and the investors party thereto. These notes were convertible by the Reporting Person starting December 16, 2017 through December 31, 2017."},{"field":"reported_value","element":"transactionTotalValue","label":"F4","text":"On September 19, 2016, the Issuer entered into a Second Omnibus Amendment (the \"Amendment\") between the Issuer and the investors party thereto, to the Note and Warrant Purchase Agreement, which granted the Issuer the option, exercisable at any time after September 1, 2016, to mandatorily convert all notes issued pursuant to the Note and Warrant Purchase Agreement into shares of the Issuer's common stock at $5.00 per share (subject to certain adjustments) (the \"Mandatory Conversion\"). On September 19, 2016, the Issuer exercised its Mandatory Conversion option under the Amendment, and on September 21, 2016 caused the conversion of $640,000 in aggregate principal amount of the Reporting Person's notes, with accrued interest thereon of $46,638.05, at a conversion price of $5.00 per share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Six notes in the aggregate principal amount of $640,000 were purchased by the Reporting Person between September 22, 2014 and August 3, 2016 pursuant to a Note and Warrant Purchase Agreement, dated as of September 22, 2014, as amended (the \"Note and Warrant Purchase Agreement\"), between the Issuer and the investors party thereto. These notes were convertible by the Reporting Person starting December 16, 2017 through December 31, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On September 19, 2016, the Issuer entered into a Second Omnibus Amendment (the \"Amendment\") between the Issuer and the investors party thereto, to the Note and Warrant Purchase Agreement, which granted the Issuer the option, exercisable at any time after September 1, 2016, to mandatorily convert all notes issued pursuant to the Note and Warrant Purchase Agreement into shares of the Issuer's common stock at $5.00 per share (subject to certain adjustments) (the \"Mandatory Conversion\"). On September 19, 2016, the Issuer exercised its Mandatory Conversion option under the Amendment, and on September 21, 2016 caused the conversion of $640,000 in aggregate principal amount of the Reporting Person's notes, with accrued interest thereon of $46,638.05, at a conversion price of $5.00 per share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Six notes in the aggregate principal amount of $640,000 were purchased by the Reporting Person between September 22, 2014 and August 3, 2016 pursuant to a Note and Warrant Purchase Agreement, dated as of September 22, 2014, as amended (the \"Note and Warrant Purchase Agreement\"), between the Issuer and the investors party thereto. These notes were convertible by the Reporting Person starting December 16, 2017 through December 31, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On September 19, 2016, the Issuer entered into a Second Omnibus Amendment (the \"Amendment\") between the Issuer and the investors party thereto, to the Note and Warrant Purchase Agreement, which granted the Issuer the option, exercisable at any time after September 1, 2016, to mandatorily convert all notes issued pursuant to the Note and Warrant Purchase Agreement into shares of the Issuer's common stock at $5.00 per share (subject to certain adjustments) (the \"Mandatory Conversion\"). On September 19, 2016, the Issuer exercised its Mandatory Conversion option under the Amendment, and on September 21, 2016 caused the conversion of $640,000 in aggregate principal amount of the Reporting Person's notes, with accrued interest thereon of $46,638.05, at a conversion price of $5.00 per share of common stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Six notes in the aggregate principal amount of $640,000 were purchased by the Reporting Person between September 22, 2014 and August 3, 2016 pursuant to a Note and Warrant Purchase Agreement, dated as of September 22, 2014, as amended (the \"Note and Warrant Purchase Agreement\"), between the Issuer and the investors party thereto. These notes were convertible by the Reporting Person starting December 16, 2017 through December 31, 2017."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"On September 19, 2016, the Issuer entered into a Second Omnibus Amendment (the \"Amendment\") between the Issuer and the investors party thereto, to the Note and Warrant Purchase Agreement, which granted the Issuer the option, exercisable at any time after September 1, 2016, to mandatorily convert all notes issued pursuant to the Note and Warrant Purchase Agreement into shares of the Issuer's common stock at $5.00 per share (subject to certain adjustments) (the \"Mandatory Conversion\"). On September 19, 2016, the Issuer exercised its Mandatory Conversion option under the Amendment, and on September 21, 2016 caused the conversion of $640,000 in aggregate principal amount of the Reporting Person's notes, with accrued interest thereon of $46,638.05, at a conversion price of $5.00 per share of common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are held in the name of the Thomas T. and Elizabeth C. Tierney Family Trust of which Mr. Tierney is a trustee."}],"derivative":{"exercise_price":5,"exercise_date":"2016-09-01","expiration_date":"2017-12-31","underlying":"Common Stock","underlying_shares":137328},"source":{"system":"sec-edgar","filing":"0001615774-16-007365","document":"s104200_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577416007365/s104200_form4.xml","form_type":"4"}},{"id":4596764,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":180680,"kind":"person","name":"TIERNEY THOMAS T","position":1,"cik":"0001571328","reported_name":"TIERNEY THOMAS T","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-09-24T00:27:26.000Z","date":"2016-09-21","kind":"exercise","acquired":true,"shares":137328,"price":5,"value":686640.0,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"All information provided herein has been adjusted where necessary to give effect to the 1-for-200 reverse stock split effected on September 21, 2016."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities are held in the name of the Thomas T. and Elizabeth C. Tierney Family Trust of which Mr. Tierney is a trustee."}],"balance_after":184345,"source":{"system":"sec-edgar","filing":"0001615774-16-007365","document":"s104200_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577416007365/s104200_form4.xml","form_type":"4"}}]}